AR028983A1 - Composiciones farmaceuticas que contienen nicotina o un ligando de los receptores nicotinicos y un inhibidor de la monoamina oxidasa y su aplicacion en la abstinencia de tabaco - Google Patents

Composiciones farmaceuticas que contienen nicotina o un ligando de los receptores nicotinicos y un inhibidor de la monoamina oxidasa y su aplicacion en la abstinencia de tabaco

Info

Publication number
AR028983A1
AR028983A1 ARP000100404A ARP000100404A AR028983A1 AR 028983 A1 AR028983 A1 AR 028983A1 AR P000100404 A ARP000100404 A AR P000100404A AR P000100404 A ARP000100404 A AR P000100404A AR 028983 A1 AR028983 A1 AR 028983A1
Authority
AR
Argentina
Prior art keywords
pharmaceutical compositions
inhibitor
monoamine
oxidase
bind
Prior art date
Application number
ARP000100404A
Other languages
English (en)
Spanish (es)
Inventor
Dominique Caille
Pascal George
Samir Jegham
Pascale Robineau
Bernard Scatton
Branamir Zivkovic
Original Assignee
Sanofi Synthelabo
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sanofi Synthelabo filed Critical Sanofi Synthelabo
Publication of AR028983A1 publication Critical patent/AR028983A1/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/465—Nicotine; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/535—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one oxygen as the ring hetero atoms, e.g. 1,2-oxazines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
    • A61P25/34—Tobacco-abuse
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Addiction (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Psychiatry (AREA)
  • Biomedical Technology (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
ARP000100404A 1999-02-02 2000-01-31 Composiciones farmaceuticas que contienen nicotina o un ligando de los receptores nicotinicos y un inhibidor de la monoamina oxidasa y su aplicacion en la abstinencia de tabaco AR028983A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR9901144A FR2788982B1 (fr) 1999-02-02 1999-02-02 Compositions pharmaceutiques contenant de la nicotine et leur application dans le sevrage tabagique

Publications (1)

Publication Number Publication Date
AR028983A1 true AR028983A1 (es) 2003-06-04

Family

ID=9541474

Family Applications (1)

Application Number Title Priority Date Filing Date
ARP000100404A AR028983A1 (es) 1999-02-02 2000-01-31 Composiciones farmaceuticas que contienen nicotina o un ligando de los receptores nicotinicos y un inhibidor de la monoamina oxidasa y su aplicacion en la abstinencia de tabaco

Country Status (8)

Country Link
EP (1) EP1150715A1 (fr)
JP (1) JP2002536342A (fr)
AR (1) AR028983A1 (fr)
AU (1) AU2298800A (fr)
CA (1) CA2361437A1 (fr)
FR (1) FR2788982B1 (fr)
HU (1) HUP0201279A2 (fr)
WO (1) WO2000045846A1 (fr)

Families Citing this family (34)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6605610B1 (en) * 1997-12-31 2003-08-12 Pfizer Inc Aryl fused azapolycyclic compounds
ME00459B (me) 1997-12-31 2011-10-10 Pfizer Prod Inc Aril fuzirana azapoliciklična jedinjenja
NZ510287A (en) 1998-11-27 2003-05-30 Neurosearch As 8-azabicyclo[3.2.1]oct-2-ene and -octane derivatives useful as cholinergic ligands at the nicotinic acetyl choline receptor
IL137937A0 (en) * 1999-08-27 2001-10-31 Pfizer Prod Inc A pharmaceutical composition for the prevention and treatment of nicotine addiction in a mammal
DK1358177T3 (da) 2000-10-13 2006-12-04 Neurosearch As Behandling af affektbetonede lidelser ved den kombinerede virkning af en nikotinreceptoragonist og et monoaminergt stof
AU2002234836B2 (en) * 2001-04-20 2007-08-23 Pfizer Products Inc. Process for the preparation of 1,3-substituted indenes and aryl-fused azapolycyclic compounds
SE521512C2 (sv) 2001-06-25 2003-11-11 Niconovum Ab Anordning för administrering av en substans till främre delen av en individs munhåla
ATE427745T1 (de) 2001-11-05 2009-04-15 Krele Pharmaceuticals Llc Zusammensetzungen und verfahren zur erhíhung der compliance mit therapien unter verwendung von aldehyddehydrogenase-hemmern und zur behandlung von alkoholsmus
MXPA04010190A (es) * 2002-04-18 2005-02-03 Astrazeneca Ab Compuestos heterociclicos.
BR0309343A (pt) * 2002-04-18 2005-02-15 Astrazeneca Ab Composto, composição farmacêutica, uso de um composto, e, método de tratamento ou profilaxia de doenças ou condições humanas
BR0309342A (pt) * 2002-04-18 2005-02-15 Astrazeneca Ab Composto, composição farmacêutica, uso de um composto, e, método de tratamento ou profilaxia de doenças ou condições humanas
CA2495248A1 (fr) 2002-08-30 2004-03-11 Memory Pharmaceuticals Corporation Derives d'anabaseine utiles pour le traitement de maladies neurodegeneratives
CA2499128C (fr) 2002-09-25 2012-07-31 Memory Pharmaceuticals Corporation Indazoles, benzothiazoles et benzoisothiazoles, leur preparation et leurs utilisations
JP4708795B2 (ja) 2002-12-20 2011-06-22 ニコノヴァム エービー 物理的および化学的に安定なニコチン−含有粒状物質
IL155666A (en) * 2003-04-29 2013-12-31 Neurim Pharma 1991 Insomnia treatment
DE10338174A1 (de) * 2003-08-20 2005-03-24 Lts Lohmann Therapie-Systeme Ag Transdermale Arzneimittelzubereitungen mit Wirkstoffkombinationen zur Behandlung der Parkinson-Krankheit
US7396833B2 (en) 2003-12-22 2008-07-08 Memory Pharmaceuticals Corporation Indoles, 1H-indazoles, 1,2-benzisoxazoles, and 1,2-benzisothiazoles, and preparation and uses thereof
RU2417225C2 (ru) 2004-03-25 2011-04-27 Мемори Фармасьютиклз Корпорейшн Индазолы, бензотиазолы, бензоизотиазолы, бензизоксазолы и их получение и применение
ATE487716T1 (de) 2004-04-22 2010-11-15 Memory Pharm Corp Indole, 1h-indazole, 1,2-benzisoxazole, 1,2- benzoisothiazole, deren herstellung und verwendungen
AU2005243147A1 (en) 2004-05-07 2005-11-24 Memory Pharmaceuticals Corporation 1H-indazoles, benzothiazoles, 1,2-benzoisoxazoles, 1,2-benzoisothiazoles, and chromones and preparation and uses thereof
US7459469B2 (en) 2004-11-10 2008-12-02 Targacept, Inc. Hydroxybenzoate salts of metanicotine compounds
JP2008525464A (ja) 2004-12-22 2008-07-17 メモリー・ファーマシューティカルズ・コーポレイション α−７ニコチン性受容体リガンド並びにその製造及び使用
US8106066B2 (en) 2005-09-23 2012-01-31 Memory Pharmaceuticals Corporation Indazoles, benzothiazoles, benzoisothiazoles, benzisoxazoles, pyrazolopyridines, isothiazolopyridines, and preparation and uses thereof
EP1976519A2 (fr) * 2006-01-27 2008-10-08 Yale University Analogues de cystisine et d'acétylcholine et procédés de traitement des troubles de l'humeur
AU2007224584A1 (en) 2006-03-16 2007-09-20 Niconovum Ab Improved snuff composition
US8017785B2 (en) 2006-05-09 2011-09-13 Astrazeneca Ab Salt forms of (2S)-(4E)-N-methyl-5-[3-(5-isopropoxypyridin)y1]-4-penten 2-amine
TWI389889B (zh) 2006-05-09 2013-03-21 Targacept Inc （２ｓ）-（４ｅ）-ｎ-甲基-５-〔３-（５-異丙氧基吡啶）基〕-４-戊烯-２-胺之新穎多晶型
US20100028447A1 (en) * 2007-01-22 2010-02-04 Targacept, Inc. Intranasal, Buccal, And Sublingual Administration Of Metanicotine Analogs
US8697722B2 (en) * 2007-11-02 2014-04-15 Sri International Nicotinic acetylcholine receptor modulators
WO2009058120A1 (fr) * 2007-11-02 2009-05-07 Sri International Modulateurs des récepteurs nicotiniques de l'acétylcholine
EP2523562B1 (fr) 2010-01-11 2019-01-02 Astraea Therapeutics, LLC Modulateurs du récepteur nicotinique de l'acétylcholine
MX2012013193A (es) 2010-05-20 2012-12-17 Astrazeneca Ab Nuevo proceso para preparar aminas olefinicas sustituidas con arilo.
US20130165511A1 (en) 2010-09-01 2013-06-27 TONIX Pharmaceuticals Holding Corp Treatment for cocaine addiction
US10653639B2 (en) * 2016-05-16 2020-05-19 Cv Sciences, Inc. Pharmaceutical formulations containing cannabidiol and nicotine for treating smokeless tobacco addiction

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2446895A (en) * 1994-04-22 1995-11-16 Assistance Publique - Hopitaux De Paris Use of mao-a inhibitors for the manufacture of a medicament in the treatment of tobacco withdrawal symptoms in smokers
US5803081A (en) * 1996-06-28 1998-09-08 Regent Court Technologies Tobacco and related products

Also Published As

Publication number Publication date
WO2000045846A1 (fr) 2000-08-10
FR2788982B1 (fr) 2002-08-02
AU2298800A (en) 2000-08-25
JP2002536342A (ja) 2002-10-29
EP1150715A1 (fr) 2001-11-07
HUP0201279A2 (en) 2002-09-28
CA2361437A1 (fr) 2000-08-10
FR2788982A1 (fr) 2000-08-04

Similar Documents

Publication Publication Date Title
AR028983A1 (es) Composiciones farmaceuticas que contienen nicotina o un ligando de los receptores nicotinicos y un inhibidor de la monoamina oxidasa y su aplicacion en la abstinencia de tabaco
PT1305286E (pt) Ciclopentanoindoles composicoes que contem os referidos compostos e metodos de tratamento
PE20020521A1 (es) Compuestos heterociclicos sustituidos para tratar la resistencia a multiples drogas
NO20024221D0 (no) Blandinger inneholdende alfa-2-adrenerge agonistkomponenter
BR0116452A (pt) Composto, composição farmacêutica, uso de um composto
PA8513601A1 (es) Composiciones farmaceuticas de inhibidores de la glucogenofosforilasa
NO20031179D0 (no) Chemokin-reseptorbindende heterocykliske forbindelser
EE200000435A (et) Asendatud oksoasaheterotsüklilised ühendid faktori Xa inhibiitoritena, neid sisaldav farmatseutiline kompositsioon ning meetod faktori Xa toime pärssimiseks
AR029838A1 (es) Heterociclos benzonitrogenados sustituidos
DE69835225D1 (de) Methode zur behandlung von durch glycocorticoidstörungen verursachten psychosen
NO20020759D0 (no) N<o>6</o> heterocykliske substituerte adenosinderivater
CA2427988A1 (fr) Composition deodorante contre les odeurs de tabac, deodorant contre les odeurs de tabac presentant une odeur de fumee secondaire reduite, et emballage de cigarettes
AU2002367060A8 (en) Heterocyclic modulators of nuclear receptors
BR0312293A (pt) Método para promover a abstinência do fumo
CA2427983A1 (fr) Composition parfumee desodorisante contre les odeurs de tabac, agent desodorisant contre les odeurs de tabac, cigarettes a odeur de fumee secondaire reduite, et emballage pour tabac
TR199800011T1 (xx) Benzo$g] kuinolin t�revleri
ES2175231T3 (es) Nuevas anfetaminas activadas.
DK1063995T3 (da) Kombination til behandling af alkoholafhængighed indeholdende en opiod-antagonist og en NMDA-receptorkompleks-modulator
PT1296976E (pt) Derivados de 1,3-di-hidro-2h-indol-2-ona e a sua utilizacao como ligandos dos receptores v1b e via da arginina-vasopressina
ATE293691T1 (de) Myostatin genpromoter und inhibierung dessen aktivierung
MY129668A (en) Use of cgrp antagonists and cgrp release inhibitors for combating menopausal hot flushes
DE60228579D1 (de) Ge von antipsychotika
UY28120A1 (es) Derivados de 3h-quinazolin-4-ona
ATE266420T1 (de) Kombinationspräparat, das selektive nmda nr2b- antagonisten und cox-2 inhibitoren enthält
EA200100917A1 (ru) Курительное изделие

Legal Events

Date Code Title Description
FA Abandonment or withdrawal